- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05904158
Effects of Platelet-Rich Fibrin in Patients With Anterior Cruciate Ligament Reconstruction
June 6, 2023 updated by: SERDAR DEMIRCI, Hacettepe University
Effects of Platelet-Rich Fibrin on Knee Muscle Strength and Function in Patients With Anterior Cruciate Ligament Reconstruction
The study was conducted to investigate the effects of platelet-rich fibrin on knee stability, knee muscle strength and knee function in patients with ACL reconstruction.
Thirty patients with ACL reconstruction were included to the study and randomly divided into two groups.
Patients were assessed preoperative and at the postoperative 1-year.
Study Overview
Status
Completed
Detailed Description
The study was conducted yo investigate the effects of platelet-rich fibrin (PRF) on the knee stability and function in patients with anterior cruciate ligament (ACL) reconstruction.
Thirty patients with ACL reconstruction were included to the study and randomly divided into two groups (PRF group and control group).
Hamstring tendon autograft was used in all patients for the reconstruction of the teared ACL.
A standardized postoperative rehabilitation program was applied to all patients.
Patients' knee stability, knee muscle strength and knee function were assessed preoperatively and one-year postoperatively.
Knee stability was assessed using KT-2000 Knee Arthrometer.
Quadriceps femoris and hamstring muscle strength measurements were conducted with an isokinetic dynamometer at 60˚/sec and 180˚/sec angular velocities.
One Leg Hop (OLH) and Y-Balance tests, and International Knee Documentation Committee (IKDC) were used to evaluate the knee function.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 4
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being isolated ACL reconstruction,
- Being between the ages of 18-45 years,
- Performing sports recreationally or professionally
Exclusion Criteria:
- Having previous knee surgery,
- Having systematic disease,
- Having multiple ligament injury on the knee or additional cartilage injuries
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PRF Group
Patients in this group, received PRF application during the standard ACL reconstruction surgery
|
Plateleth-rich fibrin was obtained from patients own blood (40 cc) and applied to the tunnels which were drilled for ACL graft
|
|
Active Comparator: Control Group
Patients in this group received a standard ACL reconstruction surgery without any other intervention.
|
This was a control group where patients received Standard ACL reconstruction surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the Knee Laxity
Time Frame: Preoperatively ans one year postoperatively
|
Knee laxity was measured using Kneelax-3 Knee arthrometer
|
Preoperatively ans one year postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the Knee Muscle Strenght
Time Frame: Preoperatively ans one year postoperatively
|
Qudriceps and hamstring muscle strength were measured using an isokinetic dynamometer
|
Preoperatively ans one year postoperatively
|
|
Changes in the Knee Function
Time Frame: Preoperatively and one year postoperatively
|
Knee function was assessed with one leg hop (OLH) test and Y-Balance tests
|
Preoperatively and one year postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2010
Primary Completion (Actual)
August 20, 2022
Study Completion (Actual)
August 20, 2022
Study Registration Dates
First Submitted
May 27, 2023
First Submitted That Met QC Criteria
June 6, 2023
First Posted (Actual)
June 15, 2023
Study Record Updates
Last Update Posted (Actual)
June 15, 2023
Last Update Submitted That Met QC Criteria
June 6, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- E-18-2060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Effects of Platelet-Rich Fibrin on Knee Stability and Knee Function
-
Al-Azhar UniversityEnrolling by invitationEffect of Piezocision and Injectable Platelets Rich Fibrin on Tooth MovementEgypt
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationCompletedKnee Injuries | Platelet-Rich Plasma | Meniscus DisorderTaiwan
-
University of UtahCompletedPlatelet-Rich Plasma (PRP) | Knee Osteoarthritis (OA)United States
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationCompleted
-
Benha UniversityNot yet recruitingCorticosteroid | Platelet Rich Plasma | Osteoarthritis Knee
-
University of BelgradeFaculty of Medicine, University of BelgradeCompletedKnee Injuries | Anterior Cruciate Ligament Injury | Sensory Disorders | Bone-Patellar Tendon-Bone Autograft | Platelet-Rich Fibrin (PRF)Serbia
-
Centre Hospitalier Universitaire, AmiensRecruitingKnee Osteoarthritis | Hyaluronic Acid | Platelet Rich PlasmaFrance
-
Hebei Medical University Third HospitalCompletedKnee Osteoarthritis | Physical Exercise | Platelet-rich PlasmaChina
-
Pamukkale UniversityNot yet recruitingKnee Arthritis Osteoarthritis | Platelet Rich Plasma Injection | Conditioned Serum
-
Mohammed Nasser AlhajjMansoura UniversityCompletedTo Evaluate the Clinical and Radiographic Effect of Platelet-rich Fibrin in Treatment of Necrotic Permanent Teeth with Open ApicesEgypt
Clinical Trials on Platelet-Rich Fibrin during Standard ACL reconstruction surgery
-
Rhode Island HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Hospital for Special Surgery, New YorkMusculoskeletal Transplant FoundationWithdrawnTendon Injuries | Rotator CuffUnited States
-
National Children's Medical Center, UzbekistanCompletedBladder Exstrophy-Epispadias ComplexUzbekistan
-
Dublin Dental University HospitalRecruitingDental Implant | Implant Stability | L-PRF | Marginal Bone LevelsIreland
-
Mustafa Kemal UniversityCompletedPostoperative Pain | Postoperative Edema | Impacted Third Molar ToothTurkey
-
Ataturk UniversityCompleted
-
University of BelgradeFaculty of Medicine, University of BelgradeCompletedKnee Injuries | Anterior Cruciate Ligament Injury | Sensory Disorders | Bone-Patellar Tendon-Bone Autograft | Platelet-Rich Fibrin (PRF)Serbia
-
Brian WaltersCompletedPost Operative PainUnited States
-
The University of Texas Health Science Center at...Completed
-
Cairo UniversityUnknown